Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein.

References

1. Buckland R., Wild T. F. 1989; Leucine zipper motif extends. Nature 547:6216
   [Google Scholar]
2. Buckland R., Gerald C., Barker R., Wild T. F. 1987; Fusion glycoprotein of measles virus: nucleotide sequence of the gene and comparison with other paramyxoviruses. Journal of General Virology 68:1695–1703
   [Google Scholar]
3. Buckland R., Malvoisin E., Beauverger P., Wild T. F. 1992; A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. Journal of General Virology 73:1703–1707
   [Google Scholar]
4. Giraudon P., Wild T. F. 1985; Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144:46–58
   [Google Scholar]
5. Horta-Barbosa L. R., Hamilton B., Wittig B., Fucillo P., Sever J. L. 1971; Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsies. Science 173:840–841
   [Google Scholar]
6. Hull J. D., Krah D. L., Choppin P. W. 1987; Resistance of a measles virus mutant to fusion inhibitory oligopeptides is not associated with mutations in the fusion peptide. Virology 159:368–372
   [Google Scholar]
7. Lambert D. M., Barney S., Lambert A. L., Guthrie K., Medinas R., Davis D. E., Bucy T., Erickson J., Merutka G., Petteway S. R.Jr 1996; Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proceedings of the National Academy of Sciences USA: 932186–2191
   [Google Scholar]
8. Malvoisin E., Wild T. F. 1990; Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. Journal of Virology 164:5160–5162
   [Google Scholar]
9. Matthews T. J., Wild C., Chen C. H., Bolognesi D. P., Greenberg M. 1994; Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunological Reviews 140:93–104
   [Google Scholar]
10. Norrby E. 1971; The effect of a carbobenzoxy tripeptide on the biological activities of measles virus. Virology 44:599–608
    [Google Scholar]
11. Richardson C. D., Scheid A., Choppin P. W. 1980; Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology 105:205–222
    [Google Scholar]
12. Wild C. T., Shugars D. C., Greenwell T. K., McDanal C. B., Matthews T. J. 1994; Peptides corresponding to a predictive alpha- helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors ofvirus infection. Proceedings ofthe NationalAcademy ofSciences USA: 919770–9774
    [Google Scholar]
13. Wild T. F., Huppert J. 1980; Specificity of measles virus and canine distemper virus antibodies. Annals of Virology 131:73–84
    [Google Scholar]
14. Wild T. F., Bernard A., Spehner D., Drillien R. 1992; Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. Journal of General Virology 73:359–367
    [Google Scholar]
15. Wild T. F., Fayolle J., Beauverger P., Buckland R. 1994; Measles virus fusion: role of the cysteine-rich region of the fusion glycoprotein. Journal of Virology 68:7546–7548
    [Google Scholar]